甘李藥業(603087.SH):擬變更公司經營範圍
格隆匯 7 月 7日丨甘李藥業(603087.SH)公佈,公司第三屆董事會第十三次會議召開,審議通過了《關於變更公司經營範圍的議案》;
同意將公司的經營範圍變更為“研製生物製品、生物原料藥、小容量重組產品注射劑;開發生物製品;銷售自產產品;貨物專用運輸(冷藏保鮮):批發醫療器械II類(6841醫用化驗和基礎設備器具、6815注射穿刺器械、6840臨牀檢驗分析儀器及診斷試劑(僅限不需冷鏈儲運診斷試劑));批發和零售醫療器械(限I類)(不涉及國營貿易管理商品:涉及配額、許可證管理商品的按國家有關規定辦理申請手續)。(該企業於2010年03月10日由內資企業變更為外商投資企業;依法須經批准的項目,經相關部門批准後依批准的內容開展經營活動。)”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.